RHENMAN & PARTNERS ASSET MANAGEMENT AB – Apellis Pharmaceuticals, Inc. Transaction History
RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:
$13.30M
portfolio value
RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.76% | 10K shares | 3.81M | $68.3 | 220K |
| Q2 2022 | share | Decrease | -44.30% | -167K shares | -9.65M | $45.22 | 210K |
| Q1 2022 | share | Decrease | -12.33% | -53K shares | -1.46M | $50.81 | 377K |
| Q4 2021 | share | Decrease | -23.39% | -131.26K shares | 2.12M | $47.95 | 430K |
| Q3 2021 | share | Increase | +84.02% | 256.26K shares | -777K | $32.96 | 561.26K |
| Q2 2021 | share | Increase | +12.96% | 35K shares | 7.69M | $63.2 | 305K |
| Q1 2021 | share | 0.00% | 0 shares | -3.85M | $42.91 | 270K | |
| Q4 2020 | share | Increase | +20.00% | 45K shares | 8.65M | $57.2 | 270K |
| Q3 2020 | share | Increase | +36.36% | 60K shares | 1.39M | $30.17 | 225K |
| Q2 2020 | share | Increase | +65.00% | 65K shares | 2.71M | $32.66 | 165K |
| Q1 2020 | share | Increase | +25.00% | 20K shares | 229K | $26.79 | 100K |
| Q4 2019 | share | Increase | 0.00% | 80K shares | 2.45M | $30.62 | 80K |